Get started
Marketik

Poised for Breakout with Strong Q4 Results and Strategic Merger

Long
SUN PHARMACEUTICAL (NSE:SUNPHARMA)  
Marketik  
NSE:SUNPHARMA   SUN PHARMACEUTICAL
Fundamental Analysis Beyond Technical Analysis Trend Analysis
4
0
fundamental beyondta trendanalysis

✅ Sun Pharmaceutical Industries is forming a symmetrical triangle pattern with support around INR 1,450 and resistance at INR 1,560. A breakout above 1,560 could signal a strong upward movement towards INR 1,650 and beyond.

✅ Sun Pharma reported a projected net profit increase of 18.4% for Q4 FY24, reaching INR 2,347 crore. The company has also recently secured shareholder approval for its merger with Taro Pharmaceutical Industries, expected to close soon, which will enhance its global market presence and capabilities.
Join our community in telegram for real time updates --- telegram.me/marketiik

Telegram- telegram.me/marketiik

A simple trader, distancing from the fake crowd. Simplifying complexity, I prioritize genuine insights over trends.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.